Karyopharm Therapeutics competitors

Karyopharm Therapeutics's competitors include Affigen, Merrimack Pharmaceuticals, TESARO and AVEO Pharmaceuticals
Add company...
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Affigen
Affigen develops tumor-identifying therapies to treat cancer.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
TESARO
TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.
AVEO Pharmaceuticals
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
Founding Date
Founding Date
2008
Founding Date
2016
Founding Date
2000
Founding Date
2010
Founding Date
2001
Type
Type
Subsidiary
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Newton, US HQ
München, DE
Locations
St. Louis, US HQ
Locations
Cambridge, US HQ
Locations
Waltham, US HQ
Locations
Cambridge, US HQ
Employees
Employees
N/A
Employees
8
Employees
294
Employees
446
Employees
20
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
75.4 m
Valuation ($)
2.1 b
Valuation ($)
344 m
Facebook likes
Facebook likes
126
Facebook likes
N/A
Facebook likes
647
Facebook likes
N/A
Facebook likes
445
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.1 k
Twitter followers
1.8 k
Twitter followers
650

Financial

Net income
Net income
($109.6m) (FY, 2016)
Net income
N/A
Net income
$470.9m (FY, 2017)
Net income
($496.1m) (FY, 2017)
Net income
($26.9m) (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 248.7m
Total funding raised
$ 17m
Total funding raised
$ 79.4m
Total funding raised
$ 161m
Total funding raised
$ 138.2m
For sources of this data, please see the company profileDownload Excel

View company profiles

Affigen
HQ
St. Louis, US
Employees
8

Affigen develops tumor-identifying therapies to treat cancer.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
294

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company
TESARO
HQ
Waltham, US
Employees
446

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

View company
AVEO Pharmaceuticals
HQ
Cambridge, US
Employees
20

AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.

View company